Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Carlos Salas

Physician Assistant Edinburg, TX Physician Assistant

NPI 1144845249 CMS profile 11254094

315 E Palm Dr Suite B, Edinburg, TX 78539

Open in the dashboard

General payments

$9,109

223 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Carlos Salas of Edinburg, TX is reported in the CMS Open Payments database as having received $9,109 across 223 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,959 94
2024 General $1,392 30
2023 General $2,980 35
2022 General $809 20
2021 General $970 44

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carlos Salas
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Carlos Salas were reported at $2,959. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Carlos Salas Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $970 $132 $37–$438 $132
2022 $809 $155 $48–$522 $149
2023 $2,980 $167 $52–$557 $160
2024 $1,392 $178 $55–$600 $164
2025 $2,959 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novartis Pharmaceuticals Corporation $2,107 20 payments
  2. Daiichi Sankyo Inc. $999 26 payments
  3. AstraZeneca Pharmaceuticals LP $409 5 payments
  4. Lilly USA, LLC $368 14 payments
  5. AbbVie, Inc. $310 13 payments
  6. Karyopharm Therapeutics Inc. $308 11 payments
  7. Sobi, Inc $272 3 payments
  8. Janssen Biotech, Inc. $250 10 payments
  9. Rigel Pharmaceuticals, Inc. $249 7 payments
  10. Pharmacosmos Therapeutics Inc. $240 2 payments
  11. Other $3,597 112 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,165 212 payments
  2. Travel and Lodging $1,368 4 payments
  3. Education $577 7 payments
Products named General payments · program years 2021–2025
  1. ENHERTU Oncology $869 24 payments
  2. Tavalisse $249 7 payments
  3. MONOFERRIC $240 2 payments
  4. KRAZATI $240 2 payments
  5. XPOVIO $230 7 payments
  6. VENCLEXTA $184 3 payments
  7. Bavencio $181 5 payments
  8. Doptelet $150 2 payments
  9. ENHERTU Oncology $143 2 payments
  10. JARDIANCE $139 8 payments
  11. Other $4,860 198 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

95

Median for Physician Assistant: 241

Drug cost

$210,909

Median for Physician Assistant: $4,110

Branded share of claims

14.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Revlimid Lenalidomide Brand 14 $210,033
Hydroxyurea Generic 18 $360
Potassium Chloride Generic 17 $227
Anastrozole Generic 16 $123
Gabapentin Generic 18 $107
Prednisone Generic 12 $60

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$14,655

Medicare's payments for the services billed

Medicare patients

171

Average age 75

Services billed

933

93 women, 78 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 55%
Diabetes 53%
Cancer 47%
Arthritis 44%
Ischemic heart disease 38%
Depression 25%
Heart failure 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 20 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ENHERTU
  • Daiichi Sankyo Inc. $296
$296 — —
ZEPZELCA
  • JAZZ PHARMACEUTICALS INC. $135
$135 — —
LYNPARZA
  • AstraZeneca Pharmaceuticals LP $125
$125 — —
KRAZATI
  • Mirati Therapeutics, Inc. $125
$125 — —
MONOFERRIC
  • Pharmacosmos Therapeutics Inc. $115
$115 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 20 in the dashboard with a free account

Records

223 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record